North America Precision Diagnostics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Precision Diagnostics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Precision Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Precision Diagnostics Market Regional Analysis

6.2 North America Precision Diagnostics Market Revenue 2020-2028 (US$ Million)

6.3 North America Precision Diagnostics Market Forecast Analysis

7. North America Precision Diagnostics Market Analysis – by Type

7.1 Genetic Tests

7.1.1 Overview
7.1.2 Genetic Tests: North America Precision Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Esoteric Tests

7.2.1 Overview
7.2.2 Esoteric Tests: North America Precision Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. North America Precision Diagnostics Market Analysis – by Application

8.1 Oncology

8.1.1 Overview
8.1.2 Oncology: North America Precision Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Cardiology

8.2.1 Overview
8.2.2 Cardiology: North America Precision Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Respiratory Diseases

8.3.1 Overview
8.3.2 Respiratory Diseases: North America Precision Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 Immunology

8.4.1 Overview
8.4.2 Immunology: North America Precision Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. North America Precision Diagnostics Market Analysis – by End User

9.1 Clinical Laboratories

9.1.1 Overview
9.1.2 Clinical Laboratories: North America Precision Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Hospitals

9.2.1 Overview
9.2.2 Hospitals: North America Precision Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Homecare

9.3.1 Overview
9.3.2 Homecare: North America Precision Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. North America Precision Diagnostics Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Precision Diagnostics Market Breakdown, by Key Country, 2023 and 2028 (%)
10.2.1.1 North America Precision Diagnostics Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Precision Diagnostics Market Breakdown, by Type
10.2.1.1.2 US: North America Precision Diagnostics Market Breakdown, by Application
10.2.1.1.3 US: North America Precision Diagnostics Market Breakdown, by End User

10.2.1.2 Canada: North America Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Precision Diagnostics Market Breakdown, by Type
10.2.1.2.2 Canada: North America Precision Diagnostics Market Breakdown, by Application
10.2.1.2.3 Canada: North America Precision Diagnostics Market Breakdown, by End User

10.2.1.3 Mexico : North America Precision Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Precision Diagnostics Market Breakdown, by Type
10.2.1.3.2 Mexico : North America Precision Diagnostics Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Precision Diagnostics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bayer AG

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Koninklijke Philips N.V.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Lantheus Medical Imaging, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Novartis AG

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 QIAGEN

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Quest Diagnostics Incorporated

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Sanofi

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Siemens Healthineers AG

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Swiss Precision Diagnostics GmbH

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Precision Diagnostics Market

Analysis – by Type (Genetic Tests, Esoteric Tests, and Others), Application (Oncology, Cardiology, Respiratory Diseases, Immunology, and Others), and End User (Clinical Laboratories, Hospitals, Homecare, and Others)